MaterniT 21 Plus and MaterniT Genome
MaterniT 21 Plus NIPS provides results for common chromosomal abnormalities, including trisomy 21 (Down syndrome), within five days and can detect issues in twin pregnancies.
MaterniT Genome NIPS uniquely analyzes every chromosome for extra or missing parts, offering insights into potential abnormalities that may affect your baby's health. This blood test can be done as early as 9 weeks into pregnancy, without the risk of miscarriage associated with invasive methods.
A noninvasive blood testT
There are many ways to get this genetic information, including methods such as serum screens and diagnostic procedures such as amniocentesis.As a noninvasive prenatal test, MaterniT 21 PLUS is different from both. It has higher detection rates than serum screening,1 and requires only a blood sample from the mother; amniocentesis requires withdrawing fluid from around the developing baby.
CLICK CATALOUGE